Inventor
TON LOGTENBERG
Inventor
NL
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61KPreparations for medical, dental or toiletry purposes18%
C12NMicroorganisms or enzymes9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture7%
A01KAnimal husbandry5%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C40BCombinatorial chemistry2%
PatentTitleYear
12,577,306Bispecific anti PD1-anti TIM3 antibodies202612,291,798Generation of binding molecules202512,247,078ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene202512,139,548Antibody that binds ErbB-2 and ErbB-3202412,123,043Methods and means for the production of Ig-like molecules202412,060,418Bispecific IgG antibodies as T cell engagers202411,952,424Multivalent antibody202411,939,394Binding molecules that inhibit cancer growth202411,925,174Antibody producing non-human animals202411,926,859Methods and means for the production of Ig-like molecules202411,820,825Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor202311,785,924Antibody producing non-human animals202311,780,925ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene202311,773,170Antibodies that bind EGFR and cMET202311,753,470Bispecific anti PD1-anti TIM3 antibodies202311,732,043Antibodies that modulate a biological activity expressed by a cell202311,685,786Binding molecules that bind CD137 and PD-L1202311,667,714Binding molecules that modulate a biological activity expressed by a cell202311,559,049Antibody producing non-human animals202311,408,095Generation of binding molecules202211,279,770Antibody that binds ErbB-2 and ErbB-3202211,237,165Antibody producing non-human animals2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to MERUS NV (22)· patent assignee history
2022–2026Based in NL· patent location history
2024Patents assigned to FUNDACIO INST DE RECERCA BIOMEDICA (1)· patent assignee history
2024Patents assigned to FUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA (1)· patent assignee history
2024Patents assigned to INST CATALANA RECERCA ESTUDIS AVANCATS (1)· patent assignee history
2026Patents assigned to MERUS B V (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERUS NV | 22 | 2022–2026 |
| FUNDACIO INST DE RECERCA BIOMEDICA | 1 | 2024 |
| FUNDACIO INST DE RECERCA BIOMEDICA IRB BARCELONA | 1 | 2024 |
| INST CATALANA RECERCA ESTUDIS AVANCATS | 1 | 2024 |
| MERUS B V | 1 | 2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| NL | 22 | 2022–2026 |